Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David L Rimm

Showing results (181-190 of 412) with videos related to

Pageof 42
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 17, 2019
Immune Cell PD-L1 Colocalizes with Macrophages and Is Associated with Outcome in PD-1 Pathway Blockade TherapyYuting Liu, Jon Zugazagoitia, Fahad Shabbir Ahmed, et al.
Journal for Immunotherapy of Cancer|November 26, 2020
Comparison of PD-L1 protein expression between primary tumors and metastatic lesions in triple negative breast cancersMariya Rozenblit, Richard Huang, Natalie Danziger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2007
Quantitative justification of the change from 10% to 30% for human epidermal growth factor receptor 2 scoring in the American Society of Clinical Oncology/College of American Pathologists guidelines: tumor heterogeneity in breast cancer and its implications for tissue microarray based assessment of outcomeChristopher B Moeder, Jennifer M Giltnane, Malini Harigopal, et al.
Breast Cancer Research and Treatment|July 11, 2014
ERβ splice variant expression in four large cohorts of human breast cancer patient tumorsHallie Wimberly, Gang Han, Dushanthi Pinnaduwage, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 25, 2016
EGFR-GRB2 Protein Colocalization Is a Prognostic Factor Unrelated to Overall EGFR Expression or EGFR Mutation in Lung AdenocarcinomaMaria I Toki, Daniel E Carvajal-Hausdorf, Mehmet Altan, et al.
Breast Cancer Research : BCR|July 31, 2016
Quantitative assessment of the spatial heterogeneity of tumor-infiltrating lymphocytes in breast cancerNikita L Mani, Kurt A Schalper, Christos Hatzis, et al.
Cancer Research|July 5, 2005
Using a xenograft model of human breast cancer metastasis to find genes associated with clinically aggressive diseaseHarriet M Kluger, Dina Chelouche Lev, Yuval Kluger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2024
Spatially Informed Gene Signatures for Response to Immunotherapy in MelanomaThazin N Aung, Jonathan Warrell, Sandra Martinez-Morilla, et al.
Breast Cancer Research : BCR|September 14, 2012
Quantitative assessment of invasive mena isoforms (Menacalc) as an independent prognostic marker in breast cancerSeema Agarwal, Frank B Gertler, Michele Balsamo, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 27, 2023
Multiplex Immunohistochemistry and Immunofluorescence: A Practical Update for PathologistsPaul W Harms, Timothy L Frankel, Myrto Moutafi, et al.
Pageof 42

Showing results (181-190 of 412) with videos related to

Sort By:
Pageof 42
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 17, 2019
Immune Cell PD-L1 Colocalizes with Macrophages and Is Associated with Outcome in PD-1 Pathway Blockade TherapyYuting Liu, Jon Zugazagoitia, Fahad Shabbir Ahmed, et al.
Journal for Immunotherapy of Cancer|November 26, 2020
Comparison of PD-L1 protein expression between primary tumors and metastatic lesions in triple negative breast cancersMariya Rozenblit, Richard Huang, Natalie Danziger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2007
Quantitative justification of the change from 10% to 30% for human epidermal growth factor receptor 2 scoring in the American Society of Clinical Oncology/College of American Pathologists guidelines: tumor heterogeneity in breast cancer and its implications for tissue microarray based assessment of outcomeChristopher B Moeder, Jennifer M Giltnane, Malini Harigopal, et al.
Breast Cancer Research and Treatment|July 11, 2014
ERβ splice variant expression in four large cohorts of human breast cancer patient tumorsHallie Wimberly, Gang Han, Dushanthi Pinnaduwage, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 25, 2016
EGFR-GRB2 Protein Colocalization Is a Prognostic Factor Unrelated to Overall EGFR Expression or EGFR Mutation in Lung AdenocarcinomaMaria I Toki, Daniel E Carvajal-Hausdorf, Mehmet Altan, et al.
Breast Cancer Research : BCR|July 31, 2016
Quantitative assessment of the spatial heterogeneity of tumor-infiltrating lymphocytes in breast cancerNikita L Mani, Kurt A Schalper, Christos Hatzis, et al.
Cancer Research|July 5, 2005
Using a xenograft model of human breast cancer metastasis to find genes associated with clinically aggressive diseaseHarriet M Kluger, Dina Chelouche Lev, Yuval Kluger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2024
Spatially Informed Gene Signatures for Response to Immunotherapy in MelanomaThazin N Aung, Jonathan Warrell, Sandra Martinez-Morilla, et al.
Breast Cancer Research : BCR|September 14, 2012
Quantitative assessment of invasive mena isoforms (Menacalc) as an independent prognostic marker in breast cancerSeema Agarwal, Frank B Gertler, Michele Balsamo, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 27, 2023
Multiplex Immunohistochemistry and Immunofluorescence: A Practical Update for PathologistsPaul W Harms, Timothy L Frankel, Myrto Moutafi, et al.
Pageof 42